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During embryonic development of the peripheral nervous system (PNS), Schwann cell precursors mi-
grate along neuronal axons to their ﬁnal destinations, where they will myelinate the axons after birth.
While the intercellular signals controlling Schwann cell precursor migration are well studied, the in-
tracellular signals controlling Schwann cell precursor migration remain elusive. Here, using a rat primary
cell culture system, we show that Dock8, an atypical Dock180-related guanine-nucleotide exchange
factor (GEF) for small GTPases of the Rho family, speciﬁcally interacts with Nck1, an adaptor protein
composed only of Src homology (SH) domains, to promote Schwann cell precursor migration induced by
platelet-derived growth factor (PDGF). Knockdown of Dock8 or Nck1 with its respective siRNA markedly
decreases PDGF-induced cell migration, as well as Rho GTPase activation, in precursors. Dock8, through
its unique N-terminal proline-rich motif, interacts with the SH3 domain of Nck1, but not with other
adaptor proteins composed only of SH domains, e.g. Grb2 and CrkII, and not with the adaptor protein
Elmo1. Reintroduction of the proline-rich motif mutant of Dock8 in Dock8 siRNA-transfected Schwann
cell precursors fails to restore their migratory abilities, whereas that of wild-type Dock8 does restore
these abilities. These results suggest that Nck1 interaction with Dock8 mediates PDGF-induced Schwann
cell precursor migration, demonstrating not only that Nck1 and Dock8 are previously unanticipated
intracellular signaling molecules involved in the regulation of Schwann cell precursor migration but also
that Dock8 is among the genetically-conservative common interaction subset of Dock family proteins
consisting only of SH domain adaptor proteins.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
In the embryonic development of the peripheral nervous sys-
tem (PNS), Schwann cell precursors migrate along neuronal axons
to their ﬁnal destinations [1,2]. After birth, they eventually wrap
around individual axons to form myelin sheaths. Myelin sheaths
are derived from the Schwann cells’ morphologically differentiated
plasma membranes and grow to be more than one hundred times
larger than the collective surface area of the premyelination
Schwann cell plasma membranes [1,2]. Previous studies have
thoroughly explored the intercellular signaling controllingB.V. This is an open access article u
logy, National Research In-
ra, Setagaya, Tokyo 157-8535,
chi).
.
Baylor College of Medicine,Schwann cell morphological changes in cell migration and axon
wrapping. For example, growth factors such as neuregulin-1
(NRG1), neurotrophin-3 (NT3), and insulin-like growth factor 1
(IGF1) and adhesion molecules such as integrin ligands are pro-
vided by peripheral neurons and bind to their cognate receptors
expressed on Schwann cells [3–6]. Their integrated extracellular
signals are involved in regulating Schwann cell morphological
changes [3–6]. In contrast, the intracellular signaling controlling
these processes is not yet sufﬁciently understood.
Rho family small GTPases (such as RhoA, Rac1, and Cdc42) are
central players in controlling cell morphological changes by rearran-
ging cytoskeletal proteins [7,8]. Similar to Ras GTPases, Rho GTPases
act as intracellular molecular switches. Rho GTPases are biologically
active when bound to GTP, which enables them to associate with ef-
fector molecules; in contrast, they are inactive when bound to GDP,
which eliminates or diminishes their ability to bind with effectors
[7,8]. The former reaction is a rate-limiting step [7,8] and is mediated
by guanine-nucleotide exchange factors (GEFs), which serve as Rho
GTPase activators, whereas the latter reaction is mediated by GTPase-nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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The Rho family GEFs consist of more than 70 members, includ-
ing the Dbl-family proteins (of various molecular weights) and the
Dock180-related proteins (each 180 kDa) [7–10]. The Dock180-
related proteins are 11 proteins [Dock180 (now designated as
Dock1)-Dock11] that are speciﬁc for Rac1 and/or Cdc42 [11–14].
They are subdivided, based on their amino acid sequence homology
and their speciﬁcity for particular Rho GTPases, into three/four
groups: Dock-A/B (Dock1-5), Dock-C (Dock6-8), and Dock-D
(Dock9-11) [14]. They are organized by two major common do-
mains of Dock homology regions 1 and 2 (DHR1/2, also known as
CZH1/2 or Docker1/2). DHR2 is a catalytic domain whereas DHR1 is
thought to bind lipids to assist in recruitment to the plasma
membranes [14].
The Dock-A/B members (Dock1-5) have been well characterized.
In addition to DHR1/2, their members contain the single Src
homology 3 (SH3) domain and the single proline-rich region. These
domains are genetically conserved from organisms such as Cae-
norhabditis elegans to mammals [10] and are involved in the Dock-A/
B members’ interactions with the Src homology (SH) domain adaptor
proteins CrkII, Grb2, and Nck1 and with other adaptor proteins such
as Elmo1 [10–14]. Dock1's SH3 domain and proline-rich region en-
gage in domain-domain interactions with CrkII and Elmo1 and are
needed not only for migration in ﬁbroblasts and epithelial cells but
also for phagocytotic signaling of the “eat-me” signal in the immune
system [12–14]. Other regions of the Dock180-related proteins vary
among members in ways that remain to be clariﬁed [12–14].
Our previous study described how NRG1 binds Schwann cell
ErbB3/2 heterodimeric receptors and promotes cell migration spe-
ciﬁcally through Dock7 [15, 16]. Yet Schwann cells express Dock8,
which may or may not be involved in migration induced by growth
factor(s) [15]. Here, we show that Dock8 speciﬁcally mediates pla-
telet-derived growth factor (PDGF)-induced Schwann cell precursor
migration. The molecule that transmits signals between Dock8 and
the PDGF receptor is the adaptor protein Nck1, whose SH3 domain
interacts with the proline-rich region of Dock8. These results show
that the genetically-conserved protein-protein interaction observed
in Dock-A/B members is also used by Dock8.2. Materials and methods
2.1. Antibodies
The following antibodies were used: polyclonal anti-Dock8
from Takara Bio (Kyoto, Japan); monoclonal anti-Nck1, monoclonal
anti-Rac1, and monoclonal anti-Cdc42 from BD Biosciences
(Franklin Lakes, NJ, USA); monoclonal RhoA and monoclonal anti-
GST tag from Santa Cruz Biotechnology (Santa Cruz, CA, USA);
polyclonal anti-PDGF receptor alpha from Cell Signaling Technol-
ogy (Danvers, MA, USA); polyclonal anti-p75NTR from Promega
(Fitchburg, WI, USA); and monoclonal FLAG-tag, monoclonal HA-
tag, and monoclonal anti-actin from MBL (Nagoya, Japan). Perox-
idase-conjugated secondary antibodies were obtained from GE
Healthcare (Fairﬁeld, CT, USA) or Nacalai Tesque (Kyoto, Japan).
Fluorescence-labeled secondary antibodies were obtained from
Abcam (Cambridge, UK) or Life Technologies (Carlsbad, CA, USA).
2.2. siRNAs
The target sequences (#1 and #2) for Dock8 were 5′-GAATG-
TAGGACTTTGCAGC-3′ and 5′-GTTACATCCTGAAACGTCG-3′, respec-
tively. Since siRNA#1 is more effective at knocking down proteins
compared to siRNA#2, siRNA#1 was used as Dock8 siRNA except in
the ﬁrst experiment. The target sequence for Nck1 was 5′-GAAT-
GAGCGATTATGGCTC-3′. The target sequence of Photinus pyralisluciferase, as the control, was 5′-AAGCCATTCTATCCTCTAGAG-3′.
2.3. Plasmid constructs
The cDNAs encoding Nck1 (GenBank Acc. No. NM_001291999),
Grb2 (GenBank Acc. No. NM_002086), and CrkII (GenBank Acc. No.
NM_016823) were ampliﬁed from human brain cDNAs (Nippon
Gene, Tokyo, Japan). These constructs were inserted into the
mammalian expression vector pCMV-GST, resulting in the ex-
pression of GST-tagged proteins at the N-terminus. Regarding
Nck1, two types of constructs carrying functionally-deﬁcient point
mutations, one with the mutation in the SH2 domain or the other
with the mutation in the SH3 domain (R308K or W38A/W143A/
W229A) [17,18], respectively, were produced using an inverse PCR-
based mutagenesis kit (Toyobo Life Science, Osaka, Japan). The
mammalian expression plasmids encoding FLAG-tagged Dock8
and HA-tagged Elmo1 (human origins) were constructed as pre-
viously described [19]. Mutations into alanine on Dock8's unique
proline-rich sequence (P187VPECP192 to AVAECA) were also pro-
duced by triple cycles of inverse PCR-based mutagenesis, resulting
in the loss of potential SH3 domain ligand activity. The Escherichia
coli expression plasmids encoding active Rac1 GTP and
Cdc42 GTP-binding domain (CRIB) of Pak1 and active RhoA GTP-
binding domain (RBD) of mDia1 were constructed as previously
described [19].
2.4. Schwann cell precursor culture and transfection
Primary Schwann cell precursors or neurons were prepared
from dorsal root ganglia (DRGs) of male or female Sprague-Dawley
rats (Sankyo Laboratories) on embryonic day 14 and cultured in
culture medium at 37 °C, as previously described [19–22]. The
siRNAs and/or plasmids were transfected into primary Schwann
cell precursors using Nucleofector II device (Lonza, Basel, Swit-
zerland) with Basic Neuron Nucleofector kit (Lonza; a Nucleofector
II program A33 protocol). Culture medium was replaced 24 h
posttransfection. To conﬁrm cell viability under these experi-
mental conditions, cells were stained with 0.4% trypan blue.
Stained attached cells routinely accounted for less than 5% of all
cells 48 h posttransfection.
2.5. Schwann cell precursor migration and immunoﬂuorescence
To enable us to mimic Schwann cell precursor migration from
ganglia, Schwann cell precursor migration was measured using
reaggregated precursors essentially as previously described [22].
Reaggregates were formed by plating Schwann precursor cells on
Corning Ultra Low Attachment dishes (Corning, NY, USA) for 4 h
and on Petri dishes for 20 h with gentle agitation every 4–6 h.
Individual Schwann cells were allowed to migrate out of the re-
aggregates in the presence or absence of 20 ng/ml of PDGFalpha
(Peprotech, Rocky Hill, NJ, USA), NRG1 (Bio-Techne, Minneapolis,
MN, USA), NT3 (Peprotech), or IGF1 (Life Technologies) on type I
collagen-coated dishes. After incubation at 37 °C for 6 h, cells were
ﬁxed with 4% PFA solution (Nacalai Tesque), permeabilized with
0.1% Triton X-100 solution (Nacalai Tesque), and blocked with
Blocking One reagent (Nacalai Tesque). Blocked samples were
immunostained with an anti-p75NTR antibody and then with a
ﬂuorescence-labeled secondary antibody, and were mounted in
Vectashield mounting medium (Vector Laboratories, Burlingame,
CA, USA). The ﬂuorescence images were captured with a
DMI4000B ﬂuorescence microscope system (Leica, Wetzlar, Ger-
many) and analyzed with AF6000 software (Leica). 0.4% Trypan
blue-stained attached cells routinely accounted for less than 5% of
all cells after incubation for 6 h with each growth factor.
Fig. 1. Dock8 is involved in the regulation of PDGF-induced Schwann cell precursor migration. (A–C) Primary rat Schwann cell precursors were transfectedwith Dock8#1, Dock8#2,
or control luciferase siRNA. Cell lysates were used for an immunoblotting using the respective antibodies against Dock8 or the control actin or Nck1. The scanned bands were
densitometrically analyzed to identify their quantiﬁcation and were statistically analyzed. Data were evaluated using Student's t-test (**, po0.01; n¼3). In the following ex-
periments, Dock8#1 siRNA was used for Dock8 knockdown. (D, E) The reaggregates of Schwann cell precursors, which were transfected with Dock8 or control siRNA, were placed
onto type I collagen-coated dishes andwere allowed to migrate outwards from the reaggregates in the presence or absence of 20 ng/ml PDGF for 6 h. Schwann cell precursors were
immunostained with an anti-p75NTR antibody (green ﬂuorescence). The distance from the center of the reaggregates (indicated by dotted arrows) was measured and statistically
analyzed. Datawere evaluated using one-way ANOVA (**, po0.01; n¼4). Scale bars indicate 100 mm. (F–H) Similarly, Schwann cell precursor reaggregates were allowed to migrate
in the presence or absence of 20 ng/ml NRG1 [F], 20 ng/ml NT3 [G], or 20 ng/ml IGF1 [H] for 6 h. Data were evaluated using Student's t-test (**, po0.01; n¼4).
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Fig. 2. Dock8 is involved in the regulation of Rac1 and to the lesser extent Cdc42. (A–D) Schwann cell precursors were transfected with Dock8 or control siRNA. The lysates of
cells, which were treated with 20 ng/ml PDGF for 0.5 h, were used for an afﬁnity-precipitation assay using E. coli-produced GST-CRIB in order to precipitate active, GTP-
bound Rac1 and Cdc42 speciﬁcally. The scanned bands (Rac1 and Cdc42) were densitometrically analyzed. Total GTPases (Rac1 and Cdc42) were also shown. Data were
evaluated using Student's t-test (**, po0.01,*, po0.05; n¼3). (E, F) Similarly, an afﬁnity-precipitation assay with E. coli-produced GST-RBD was performed in order to
precipitate active, GTP-bound RhoA speciﬁcally. Total RhoA was also shown. Data were evaluated using Student's t-test (**, po0.01; n¼3).
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For an interaction assay [19,20], human embryonic kidney 293T
cells (Human Science Research Resources Bank, Tokyo, Japan) were
used [19,20] and transfected using CalPhos transfection reagent
(Takara Bio) according to the manufacturer's instructions.
2.7. Immunoprecipitation, afﬁnity-precipitation, and
immunoblotting
Cells or tissues were lysed in lysis buffer (50 mM HEPES-NaOH
[pH 7.5], 3 mM MgCl2, 150 mM NaCl, 1 mM dithiothreitol, 1 mM
phenylmethane sulfonylﬂuoride, 0.01 mM leupeptin, 1 mM EDTA,
1 mM Na3VO4, 10 mM NaF, 0.5% NP-40, and 1% CHAPS), to elute
cell and tissue proteins, then centrifuged in a microcentrifuge to
obtain clear supernatants [19,20]. Aliquots of the lysates were usedfor immunoprecipitation or afﬁnity-precipitation. For im-
munoprecipitation, the lysates were mixed with an ImmunoCruz
resin (Santa Cruz Biotechnology) preabsorbed with the respective
antibodies, and gently shaken for 2 h or overnight, and washed
with lysis buffer. For afﬁnity-precipitation, the same tagged pro-
tein-absorbed resin was used following immunoprecipitation. The
precipitates or lysates were denatured and placed in SDS-poly-
acrylamide gels (Bio-Rad, Hercules, CA, USA). The electro-
phoretically separated proteins were transferred to PDVF mem-
brane using Trans-Blot Turbo Transfer System (Bio-Rad), blocked
with Blocking One reagent, and immunoblotted ﬁrst with primary
antibodies and then with peroxidase-conjugated secondary anti-
bodies. The bound antibodies were detected using chemilumi-
nescence detection reagent (Nacalai Tesque). The scanned bands
were densitometrically analyzed to identify their quantiﬁcation
using UN-SCAN-IT Gel software (Silk Scientiﬁc, Orem, UT, USA).
Fig. 3. Dock8 is speciﬁcally afﬁnity-precipitated with Nck1 through Nck1's SH3 domain but not through the SH2 domain. (A–D) The lysates of rat neonatal sciatic nerve
tissues were afﬁnity-precipitated with an immobilized GST-tagged Nck1, GST-tagged Grb2, GST-tagged CrkII, or HA-tagged Elmo1 protein. The afﬁnity-precipitates were
immunoblotted with an anti-Dock8 antibody. Similarly, adaptor proteins in the precipitates were immunoblotted with an anti-GST or anti-HA antibody. The immunoblots for
total Dock8 were also shown. (E) 293T cells were transfected with the plasmids encoding GST-tagged Nck1 (the wild type or the mutant harboring SH3 domain-defective
W38A, W143A, and W229A) and FLAG-tagged Dock8. The lysates were used for an immunoprecipitation with an anti-GST antibody and the immunoprecipitates were
immunoblotted with an anti-FLAG antibody (upper panel). Total GST-Nck1 and FLAG-Dock8 were also shown (middle and lower panels). (F) Similarly, 293T cells were
transfected with the plasmids encoding GST-Nck1 (the wild type or the mutant harboring SH2 domain-defective R308K) and FLAG-Dock8.
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To detect any active GTP-bound forms of Rho GTPases in the
lysates (0.1 mg of the average) of Schwann cell precursors treated
with 20 ng/ml of PDGFalpha for 0.5 h, afﬁnity-precipitation was
performed using recombinant E. coli-produced GST-tagged CRIB
(speciﬁc for Rac1 GTP and Cdc42 GTP) or RBD (speciﬁc forRhoA GTP) proteins (0.02 mg of glutathion resin-immobilized
recombinant protein per tube) [7,8,19]. The afﬁnity-precipitated
GTP-bound Rho GTPases were detected using immunoblotting
with each anti-Rho GTPase antibody. The amounts of total Rho
GTPase proteins in the cell lysates were also compared using im-
munoblotting. The scanned bands were densitometrically ana-
lyzed as a means of quantiﬁcation.
Fig. 4. Nck1 is involved in Schwann cell precursor migration by PDGF whose receptor associates with the cognate receptor through Nck1's SH2 domain. (A, B) Schwann cell
precursors were transfected with Nck1 or control luciferase siRNA. Cell lysates were used for an immunoblotting using the respective antibodies against Nck1 or the control
actin or Dock8. The scanned bands were densitometrically analyzed. Data were evaluated using Student's t-test (**, po0.01; n¼3). (C, D) The reaggregates of Schwann cell
precursors, which were transfected with Nck1 or control siRNA, were placed on dishes and were allowed to migrate in the presence or absence of 20 ng/ml PDGF. Data were
evaluated using one-way ANOVA (**, po0.01; n¼4). Scale bars indicate 100 mm. (E) The lysates of rat neonatal sciatic nerve tissues were afﬁnity-precipitated with an
immobilized GST-tagged Nck1 (the wild type or the mutant harboring SH2 domain-defective R308K) protein. The precipitates were also immunoblotted with an anti-GST
antibody to detect GST-Nck1. The immunoblot for the total PDGF receptor (designated as PDGFR in the panel) was also shown.
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The values shown in the ﬁgure panels represent the means 7
standard deviation from separate experiments. Comparisons between
two experimental groups were made using the unpaired Student's t-
test (**, po0.01,*, po0.05). A one-way analysis of variance (ANOVA)
was followed by a Fisher's protected least signiﬁcant difference (PLSD)
test (**, po0.01). Microsoft Excel (Redmond, WA, USA), GraphPad
Prism (La Jolla, CA, USA), or AnalystSoft StatPlus (Walnut, CA, USA) was
used for these statistical analyses.
2.10. Animal studies
Experimental animals were cared for in accordance with the
protocol approved by the Japanese National Research Institute for
Child Health and Development Animal Care Committee. The gene
recombination experiments were carried out in accordance withthe protocol approved by the Japanese National Research Institute
for Child Health and Development Gene Recombination Committee.3. Results
3.1. Dock8 is involved in PDGF-mediated Schwann cell precursor
migration
To investigate whether Dock8 is involved in rat Schwann cell
precursor migration, we transfected siRNAs (nonoverlapping
Dock8#1 and Dock8#2 siRNAs) speciﬁc for Dock8 into Schwann cell
precursors. Transfection with siRNAs #1 and #2 knocked down
expression of Dock8 proteins by approximately 95% and 80%, re-
spectively (Fig. 1A–C). Since Dock8 siRNA#1 was more effective than
siRNA#2, we used siRNA#1 in the following knockdown experi-
ments. Transfection with Dock8 siRNA speciﬁcally inhibited PDGF-
Fig. 5. Nck1 is involved in the regulation of Rho GTPases. (A–D) Schwann cell precursors were transfected with Nck1 or control siRNA. Cell lysates were used for an afﬁnity-
precipitation assay using GST-CRIB and for an immunoblotting with an anti-Rho GTPase antibody. Data were evaluated using Student's t-test (**, po0.01; n¼3). (E, F)
Similarly, an afﬁnity-precipitation assay using GST-RBD was performed. Data were evaluated using Student's t-test (**, po0.01; n¼3).
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approximately 50% (Fig. 1D and E); in contrast, Dock8 knockdown
did not affect migration induced by NRG1, NT3, or IGF1 (Fig. 1F–H).
These growth factors are known to be involved in migratory activity
for Schwann cell lineage cells [2,13]. Reaggregates seem likely to
mimic migration of Schwann cell precursors from the ganglia in
mammalian embryonic development [21,22].
Dock8 is the GEF for Rac1 and Cdc42, but its speciﬁcity for Rac1
and Cdc42 is likewise due to cell type or upstream signals [13,14].
Thus we aimed to explore the effects of Dock8 knockdown on Rac1
and Cdc42 activation. We carried out afﬁnity-precipitation assays
using GST-tagged GTP-bound Rac1 and Cdc42 domain of Pak1
(CRIB domain) in the lysates from Schwann cell precursors treated
with PDGF. Dock8 knockdown decreased the amount of GTP-
bound Rac1 by approximately 70% (Fig. 2A and B). Dock8 knock-
down also decreased the amount of GTP-bound Cdc42, but only byapproximately 10% (Fig. 2C and D). On the other hand, Dock8
knockdown did not affect GTP-bound RhoA (Fig. 2E and F). Taken
together with the results from Fig. 1, these results show that Dock8
preferentially acts upstream of Rac1 and participates in PDGF-
mediated Schwann cell precursor migration.
3.2. Nck1 interacts with Dock8 and is involved in PDGF-mediated
Schwann cell precursor migration
We next sought to identify other protein(s) interacting with
Dock8. It has been known that Dock1-Dock5 bind with SH2 and
SH3 domain adaptor proteins such as CrkII and the adaptor protein
Elmo1 [13,14]. We ﬁrst examined whether the SH2 and SH3 domain
adaptor proteins interacted with Dock8. We mixed rat sciatic nerve
tissue lysates with each of the immobilized SH2 and SH3 domain
adaptor proteins, which were ﬁrst expressed in human embryonic
Fig. 6. The proline-rich region of Dock8 is involved in the interaction with Nck1. (A) Domain organizations (unique proline-rich region [red line], DHR1, and DHR2) in human
full-length Dock8 (amino acids 1–2032) were depicted. The positions of proline (P, indicated by red squares) in its proline-rich region (amino acids 181–197) were compared
to those in other organisms. The amino acids identical to those in human Dock8 were indicated by red characters. (B) 293T cells were transfected with the plasmids encoding
FLAG-tagged Dock8 (the wild type or the mutant harboring P187A, P189A, and P192A) and GST-tagged Nck1. The lysates were used for an immunoprecipitation with an anti-
GST antibody and the immunoprecipitates were immunoblotted with anti-FLAG antibody (upper panel). Total GST-Nck1 and FLAG-Dock8 were also shown (middle and
lower panels).
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sulted in afﬁnity-precipitation with Nck1, but not with CrkII and
Grb2 (Fig. 3A–C). Dock8 did not interact with Elmo1 (Fig. 3D). We
next examined whether the SH2 or SH3 domain contributed to
Dock8 interaction. We transfected the plasmid encoding wild type
Nck1 or SH3 domain-defective Nck1 mutant (harboring Trp-to-Ala
mutation) with Dock8 into 293T cells (Fig. 3E). The lysates were
used for precipitation of wild type or mutant Nck1 with Dock8.
Dock8 was precipitated with wild type Nck1 but not with SH3
domain-defective Nck1 mutant. In similar experiments, Dock8 was
precipitated with SH2 domain-defective Nck1 mutant (harboring
Arg-to-Lys mutation, Fig. 3F). Thus Nck1 interacts with Dock8 and
their interaction involves Nck1's SH3 domain.
Given that Dock8 interacts with Nck1, we investigated whether
Nck1 is involved in Schwann cell precursor migration. We trans-
fected Nck1 siRNA into Schwann cell precursors and conﬁrmed
knockdown of Nck1 proteins in Schwann cell precursors (Fig. 4A
and B). Nck1 knockdown blocked Schwann cell precursor migra-
tion by PDGF (Fig. 4C and D). Under these conditions, PDGF re-
ceptor was indeed afﬁnity-precipitated with Nck1 and their in-
teraction occurred through Nck1's SH2 domain (Fig. 4E), sup-
porting the established data regarding the PDGF receptor and
Nck1 interaction in other cell types [23].
Next, we explored the effects of Nck1 knockdown on Rac1 and
Cdc42 activation. Nck1 knockdown decreased the formation not
only of GTP-bound Rac1 and Cdc42 but also of GTP-bound RhoA
(Fig. 5A–F). The reason why these results do not correlate with
those concerning Dock8 knockdown is probably that Nck1 has
multiple roles in various cellular events beyond cell morphological
changes. In fact, Nck1 knockout results in lethality at an early
embryonic developmental stage [24].3.3. Nck1 interaction with Dock8 is critical for Schwann cell pre-
cursor migration
To investigate the role of Nck1 interaction with Dock8 in PDGF-
mediated migration of Schwann cell precursors, we produced a
mutant construct of Dock8's proline-rich sequence (red-squared
proline in Fig. 6A). This mutant did not precipitate with Nck1
(Fig. 6B), in keeping with the result that the SH3 domain of Nck1
participates in this interaction. Thus we cotransfected wild type hu-
man Dock8 or this mutant construct into Dock8 or control siRNA-
transfected Schwann cell precursors. Reintroduction of the wild type
Dock8 construct reversed the siRNA-mediated inhibition of Schwann
cell precursor migration, whereas reintroduction of the mutant
construct did not restore migration (the 4th panel on the right versus
the 3rd panel on the right in Fig. 7A, and the 8th bar versus the 6th in
Fig. 7B), indicating that Nck1 interaction with Dock8 plays an im-
portant role in PDGF-mediated Schwann cell precursor migration.4. Discussion
Many previous studies on the molecular mechanisms underlying
Schwann cell migration have focused on how intercellular signals
between Schwann cells and peripheral neurons promote or inhibit
their migration. In contrast, the questions of which intracellular
signaling molecules, acting downstream of receptors, control
Schwann cell migration and how they control migration are still
largely unresolved. Small GTPase family members and regulators
act as intracellular switching proteins and play key roles in migra-
tion in various cell types; this makes sense given the continuous
and dynamic cell morphological changes required by the migration
Fig. 7. The proline-rich region of Dock8 is involved in PDGF-stimulated Schwann cell
precursor migration. (A, B) The reaggregates of Schwann cell precursors, which were
co-transfected with Dock8 or control siRNA7the plasmid encoding Dock8 (the wild
type or the mutant harboring P187A, P189A, and P192A) and GFP, were placed onto
type I collagen-coated dishes and were allowed to migrate outwards from the re-
aggregates in the presence or absence of 20 ng/ml PDGF for 6 h. The distance from
the center of the reaggregates was measured and statistically analyzed. Data were
evaluated using one-way ANOVA (**, po0.01; n¼4). Scale bars indicate 100 mm.
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mediator controlling Schwann cell precursor migration. Knockdown
of Dock8 in Schwann cell precursors inhibits migration by PDGF but
not by NRG1, NT3, or IGF1. Also, Dock8 knockdown preferentially
inhibits Rac1, whose activity is essential for cell migration in many
other types of cells [7,8]. Thus Dock8 is required for the regulation
of Schwann cell precursor migration; further studies may be needed
to understand whether the activity of Dock8 is spatiotemporally
regulated during the migration process.
Regulation of migration by Schwann cell growth factor receptors
is likely mediated by the respective speciﬁc Rho family GEFs. For
example, NRG1 binding to Schwann cell ErbB3/2 receptors speciﬁ-
cally activates Dock7, upregulating the activities of Rac1 and Cdc42
[15]. Conversely, knockdown of Dock7 largely inhibits NRG1-in-
duced Rac1 and Cdc42 activities. In this case, Dock7 is the ErbB2
receptor substrate; in Dock8, however, the phosphorylation site is
not conserved [15]. NT3 activation of Schwann cell TrkC receptor
also has the ability to promote the activities of Rac1 and Cdc42 in
parallel [25]; but their activation requires two different Dbl-family
GEFs. Rac1 activation is mediated by Tiam1 [26], whereas Cdc42
activation is mediated by Dbs [27]. Although the molecular re-
lationship between TrkC and Dock8 remains to be characterized, the
speciﬁc knockdown of Tiam1 or Dbs by its speciﬁc siRNA sufﬁ-
ciently inhibits NT3-induced Rac1 and Cdc42 activation [26,27]. It is
likely that Dock8 speciﬁcally acts downstream of Schwann cell
PDGF receptor and promotes migration.
Dock8 is the gene product relevant to autosomal recessive
Hyper-IgE recurrent infection syndrome. Its deﬁciency is asso-
ciated with a variant of combined immunodeﬁciency [28]. All
Dock8 mutations lead to loss of either the Dock8 protein itself or
its function. Dock8 protein is not often detected in T lymphocytes
in patients. Dock8-deﬁcient T cells exhibit normal cytotoxic ac-
tivity but impaired proliferation and activation. Dock8 likewise
responds to a speciﬁc extracellular signal. In each cell type where
Dock8 is expressed, Dock8 may be responsible for that cell type's
speciﬁc extracellular signal, as observed in the relationship be-
tween the PDGF receptor and Dock8 in Schwann cell precursors.
Dock180 is an orthologue of C. elegans cell death-5 (CED-5), which
plays the central role in phagocytosis of apoptotic cells. During pha-
gocytosis in C. elegans, CED-5 collaborates with CED-2 and CED-12,
which encode mammalian CrkII- and Elmo1-like adaptor proteins,
respectively [10,13]. In Drosophila melanogaster, the Dock180 ortholo-
gue Mbc acts in parallel with Elmo and Dcrk to regulate actin cytos-
keletal rearrangement in epithelial cells, promoting migration in dor-
sal closure and morphological differentiation in myogenesis [14]. In
mammals, two other CrkII-like adaptor proteins (Grb2 and Nck1) are
also known to interact with Dock180 [29,30]. Despite the genetically-
conserved interaction of Dock-A/B members (Dock1-Dock5) with
adaptor proteins such as CrkII and Elmo1, Dock-C/D members (Dock6-
Dock11) are not able to bind with CrkII and Elmo1. It is likewise known
that the Dock-C members Dock6 and Dock7 do not bind with CrkII or
Grb2 [15,19]. Here, we have found that Dock8, another Dock-C
member, has the ability to interact with Nck1. Thus the ability to in-
teract with SH2 and SH3 domain adaptor proteins is conserved not
only in Dock1-Dock5 but also in Dock8 (Fig. 8).
Some congenital peripheral demyelinating or dysmyelinating
neuropathies are associated with molecules involved in the regula-
tion of the Rho family GTPases, which play a central role in cell
morphological changes. Frabin (also known as FYVE, Rho-GEF and
pleckstrin homology domain containing 4 [FGD4]), a GEF speciﬁcally
activating Cdc42, is heterogeneously mutated in autosomal recessive
peripheral demyelinating Charcot-Marie-Tooth (CMT) disease type
4H [31,32]. The amino acid mutation of Arhgef10 (also called gef10) is
linked to a peripheral neuropathy associated with thinly myelinated
axons and slowed nerve conduction velocity, similar to the various
subtypes of CMT disease [33]. This makes sense as Arhgef10 is a GEF
Fig. 8. Nck1 adaptor protein's interaction with Dock8 is compared with its interactions with other Dock family proteins. C. elegans CED-5 (Dock1 orthologue) and mam-
malian Dock1-Dock5 (CED-10/Rac1-speciﬁc Dock-A/B family members) each form a complex with CED-2 (CrkII) and CED-12 (Elmo1). The complexes containing CED-5 or
Dock1 act downstream of receptors controlling phagocytosis as well as other receptors. Among the Rac1 and/or Cdc42-speciﬁc Dock-C family members, Dock8 is unique in its
interaction with Nck1. Interaction with CrkII-like adaptor proteins is not known in Cdc42-speciﬁc Dock-D family members.
Y. Miyamoto et al. / Biochemistry and Biophysics Reports 6 (2016) 113–123122speciﬁc for RhoA [34]. In CMT diseases, mutations of Frabin and
Arfgef10 are associated with hypomyelination phenotypes. Dock8
and the proteins that interact with it are not currently known to be
associated with peripheral neuropathies, but, given that thin myelin
sheath organization is often due to defective Schwann cell mor-
phological changes, it will be worth clarifying the relationship of
Dock8 and its interacting proteins to peripheral neuropathies.
In the present study, we demonstrate that Nck1's interaction
with Dock8, acting downstream of the PDGF receptor, regulates
Schwann cell precursor migration. Further studies will allow us to
understand the detailed mechanism by which the PDGF receptor,
Nck1, and Dock8 regulate Schwann cell precursor migration, but
also whether or how they regulate migration under pathological
conditions such as injury. Studies in this line may help us to elu-
cidate therapeutic target molecules promoting remyelination after
injury or reversing demyelination due to neuropathy through
promoting migration of Schwann cell precursors into their proper
positions in the nerve tissues.Conﬂict of interest
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